Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Theratechnologies can do better than the Future Pak offer, Leede says | ||
Mo | Will the Bank of Canada cut interest rates this week? | ||
Fr | Walmart is not as exposed to tariffs as you think | ||
Fr | Now's the time to buy software and SAAS stocks, Roth says | ||
Fr | Is Cogeco Communications stock a buy? | ||
Do | Tilray price target slashed at Haywood | ||
Do | Air Canada is trading at pandemic levels, analyst notes | ||
Mi | Calian is the right stock for tariff turmoil, Ventum says | ||
Mi | RBC chops price target on BCE | ||
08.04. | WELL Health's Circle Medical inquiry is "financially immaterial", Raymond James says | ||
08.04. | Can Intel's new CEO make a difference? | ||
08.04. | Medexus is a "Strong Buy", Raymond James says | ||
07.04. | $6.00 a share is fair for Converge Technology Solutions, Ventum says | ||
06.04. | Rogers Communications is facing headwinds, TD Cowen says | ||
04.04. | I'm calling bottom on Telus, Greg Newman says | ||
04.04. | BRP stock is a "Liberation Day winner", Citi says | ||
03.04. | Rubicon Organics is still a buy, Haywood says | ||
03.04. | Will BlackBerry survive tariffs? | ||
03.04. | Exro Technologies downgraded at National Bank | ||
02.04. | Organigram acquisition gets thumbs up ay Haywood | ||
02.04. | RBC maintains "Hold" rating on BlackBerry | ||
01.04. | AIDX's Orion acquisition is a game-changer, Raymond James says | ||
01.04. | Quebecor wins price target raise at TD Cowen | ||
01.04. | VEXT Science keeps buy rating at Ventum | ||
31.03. | Here's why WELL Health is down and why you should buy it: Ventum |